Systems biology of kidney diseases

Kidney International

Volumn 81, Issue 1, 2012, Pages 22-39

  He, John Cijiang ^a,b   Chuang, Peter Y ^a   Ma'Ayan, Avi ^a   Iyengar, Ravi ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

cell signaling; gene transcription; kidney disease; microarray analysis; protein interaction

Indexed keywords

AMINOGUANIDINE; MESSENGER RNA; STEROID; SULODEXIDE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA ANTIBODY;

ADVERSE OUTCOME; CYTOLOGY; DISEASE ACTIVITY; DISEASE COURSE; DISEASE MARKER; EPIGENETICS; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE IDENTIFICATION; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GLOMERULOPATHY; HIV ASSOCIATED NEPHROPATHY; HUMAN; HUMAN GENOME; IMMUNOSUPPRESSIVE TREATMENT; INFORMATION PROCESSING; KIDNEY CELL; KIDNEY DISEASE; KIDNEY FUNCTION; MATHEMATICAL MODEL; METABOLOME; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; NONHUMAN; PATHOGENESIS; PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEOMICS; REVIEW; RISK FACTOR; SEQUENCE ANALYSIS; STATISTICAL MODEL; SYSTEMS BIOLOGY; TRANSCRIPTOMICS;

EID: 83655163844     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2011.314     Document Type: Review

References (127)

1. Stranger BE, Stahl EA, Raj T. Progress and promise of genome-wide association studies for human complex trait genetics. Genetics 2010; 187: 367-383.
2. Kottgen A, Glazer NL, Dehghan A et al. Multiple loci associated with indices of renal function and chronic kidney disease. Nat Genet 2009; 41: 712-717.
3. Pezzolesi MG, Poznik GD, Mychaleckyj JC et al. Genome-wide association scan for diabetic nephropathy susceptibility genes in type 1 diabetes. Diabetes 2009; 58: 1403-1410.
4. Schelling JR, Abboud HE, Nicholas SB et al. Genome-wide scan for estimated glomerular filtration rate in multi-ethnic diabetic populations: the Family Investigation of Nephropathy and Diabetes (FIND). Diabetes 2008; 57: 235-243.
5. Feehally J, Farrall M, Boland A et al. HLA has strongest association with IgA nephropathy in genome-wide analysis. J Am Soc Nephrol 2010; 21: 1791-1797.
6. Kao WH, Klag MJ, Meoni LA et al. MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet 2008; 40: 1185-1192.
7. Kopp JB, Smith MW, Nelson GW et al. MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet 2008; 40: 1175-1184.
8. Genovese G, Tonna SJ, Knob AU et al. A risk allele for focal segmental glomerulosclerosis in African Americans is located within a region containing APOL1 and MYH9. Kidney Int 2010; 78: 698-704.
9. Sale MM, Mychaleckyj JC, Chen WM. Planning and executing a genome wide association study (GWAS). Methods Mol Biol 2009; 590: 403-418.
10. Iles MM. Genome-wide association studies. Methods Mol Biol 2011; 713: 89-103.
11. Genovese G, Friedman DJ, Ross MD et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 2010; 329: 841-845.
12. Mackay TF, Stone EA, Ayroles JF. The genetics of quantitative traits: challenges and prospects. Nat Rev Genet 2009; 10: 565-577.
13. Papeta N, Chan KT, Prakash S et al. Susceptibility loci for murine HIVassociated nephropathy encode trans-regulators of podocyte gene expression. J Clin Invest 2009; 119: 1178-1188.
14. Teer JK, Mullikin JC. Exome sequencing: the sweet spot before whole genomes. Hum Mol Genet 2010; 19: R145-R151.
15. Choi M, Scholl UI, Ji W et al. Genetic diagnosis by whole exome capture and massively parallel DNA sequencing. Proc Natl Acad Sci USA 2009; 106: 19096-19101.
16. Ng SB, Turner EH, Robertson PD et al. Targeted capture and massively parallel sequencing of 12 human exomes. Nature 2009; 461: 272-276.
17. Martini S, Eichinger F, Nair V et al. Defining human diabetic nephropathy on the molecular level: integration of transcriptomic profiles with biological knowledge. Rev Endocr Metab Disord 2008; 9: 267-274.
18. Berthier CC, Zhang H, Schin M et al. Enhanced expression of Janus kinase-signal transducer and activator of transcription pathway members in human diabetic nephropathy. Diabetes 2009; 58: 469-477.
19. Hodgin JB, Borczuk AC, Nasr SH et al. A molecular profile of focal segmental glomerulosclerosis from formalin-fixed, paraffin-embedded tissue. Am J Pathol 2010; 177: 1674-1686.
20. Peterson KS, Huang JF, Zhu J et al. Characterization of heterogeneity in the molecular pathogenesis of lupus nephritis from transcriptional profiles of laser-captured glomeruli. J Clin Invest 2004; 113: 1722-1733. (Pubitemid 39071664)
21. Ju W, Eichinger F, Bitzer M et al. Renal gene and protein expression signatures for prediction of kidney disease progression. Am J Pathol 2009; 174: 2073-2085.
22. Bhavnani SK, Eichinger F, Martini S et al. Network analysis of genes regulated in renal diseases: implications for a molecular-based classification. BMC Bioinformatics 2009; 10(Suppl 9): S3.
23. Susztak K, Bottinger E, Novetsky A et al. Molecular profiling of diabetic mouse kidney reveals novel genes linked to glomerular disease. Diabetes 2004; 53: 784-794. (Pubitemid 38270650)
24. Teramoto K, Negoro N, Kitamoto K et al. Microarray analysis of glomerular gene expression in murine lupus nephritis. J Pharmacol Sci 2008; 106: 56-67. (Pubitemid 351159069)
25. Wiggins JE, Patel SR, Shedden KA et al. NFkappaB promotes inflammation, coagulation, and fibrosis in the aging glomerulus. J Am Soc Nephrol 2010; 21: 587-597.
26. Wold B, Myers RM. Sequence census methods for functional genomics. Nat Methods 2008; 5: 19-21.
27. Pepke S, Wold B, Mortazavi A. Computation for ChIP-seq and RNA-seq studies. Nat Methods 2009; 6: S22-S32.
28. Lachmann A, Xu H, Krishnan J et al. ChEA: transcription factor regulation inferred from integrating genome-wide ChIP-X experiments. Bioinformatics 2010; 26: 2438-2444.
29. Ma'ayan A, He JC. Protein kinase target discovery from genome-wide messenger RNA expression profiling. Mt Sinai J Med 2010; 77: 345-349.
30. Schmid H, Boucherot A, Yasuda Y et al. Modular activation of nuclear factor-kappaB transcriptional programs in human diabetic nephropathy. Diabetes 2006; 55: 2993-3003. (Pubitemid 44923635)
31. Dressler GR. Epigenetics, development, and the kidney. J Am Soc Nephrol 2008; 19: 2060-2067.
32. Mohtat D, Susztak K. Fine tuning gene expression: the epigenome. Semin Nephrol 2010; 30: 468-476.
33. Kikuchi R, Yagi S, Kusuhara H et al. Genome-wide analysis of epigenetic signatures for kidney-specific transporters. Kidney Int 2010; 78: 569-577.
34. Bechtel W, McGoohan S, Zeisberg EM et al. Methylation determines fibroblast activation and fibrogenesis in the kidney. Nat Med 2010; 16: 544-550.
35. Ho J, Ng KH, Rosen S et al. Podocyte-specific loss of functional microRNAs leads to rapid glomerular and tubular injury. J Am Soc Nephrol 2008; 19: 2069-2075.
36. Shi S, Yu L, Chiu C et al. Podocyte-selective deletion of dicer induces proteinuria and glomerulosclerosis. J Am Soc Nephrol 2008; 19: 2159-2169.
37. Godwin JG, Ge X, Stephan K et al. Identification of a microRNA signature of renal ischemia reperfusion injury. Proc Natl Acad Sci USA 2010; 107: 14339-14344.
38. Wang B, Herman-Edelstein M, Koh P et al. E-cadherin expression is regulated by miR-192/215 by a mechanism that is independent of the profibrotic effects of transforming growth factor-beta. Diabetes 2010; 59: 1794-1802.
39. Chung AC, Huang XR, Meng X et al. miR-192 mediates TGF-beta/Smad3-driven renal fibrosis. J Am Soc Nephrol 2010; 21: 1317-1325.
40. Krupa A, Jenkins R, Luo DD et al. Loss of MicroRNA-192 promotes fibrogenesis in diabetic nephropathy. J Am Soc Nephrol 2010; 21: 438-447.
41. Mitchell PS, Parkin RK, Kroh EM et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008; 105: 10513-10518.
42. Liang Y, Ridzon D, Wong L et al. Characterization of microRNA expression profiles in normal human tissues. BMC Genomics 2007; 8: 166.
43. Berezikov E, Guryev V, van de Belt J et al. Phylogenetic shadowing and computational identification of human microRNA genes. Cell 2005; 120: 21-24. (Pubitemid 40094599)
44. Melkonyan HS, Feaver WJ, Meyer E et al. Transrenal nucleic acids: from proof of principle to clinical tests. Ann NY Acad Sci 2008; 1137: 73-81.
45. Hoorn EJ, Hoffert JD, Knepper MA. The application of DIGE-based proteomics to renal physiology. Nephron Physiol 2006; 104: p61-p72.
46. Magni F, Sarto C, Valsecchi C et al. Expanding the proteome twodimensional gel electrophoresis reference map of human renal cortex by peptide mass fingerprinting. Proteomics 2005; 5: 816-825. (Pubitemid 40316066)
47. Yoshida Y, Miyazaki K, Kamiie J et al. Two-dimensional electrophoretic profiling of normal human kidney glomerulus proteome and construction of an extensible markup language (XML)-based database. Proteomics 2005; 5: 1083-1096. (Pubitemid 40469037)
48. Miyamoto M, Yoshida Y, Taguchi I et al. In-depth proteomic profiling of the normal human kidney glomerulus using two-dimensional protein prefractionation in combination with liquid chromatography-tandem mass spectrometry. J Proteome Res 2007; 6: 3680-3690. (Pubitemid 47522757)
49. Oh J, Pyo JH, Jo EH et al. Establishment of a near-standard twodimensional human urine proteomic map. Proteomics 2004; 4: 3485-3497. (Pubitemid 39525299)
50. Pieper R, Gatlin CL, McGrath AM et al. Characterization of the human urinary proteome: a method for high-resolution display of urinary proteins on two-dimensional electrophoresis gels with a yield of nearly 1400 distinct protein spots. Proteomics 2004; 4: 1159-1174. (Pubitemid 38445973)
51. Pisitkun T, Shen RF, Knepper MA. Identification and proteomic profiling of exosomes in human urine. Proc Natl Acad Sci USA 2004; 101: 13368-13373. (Pubitemid 39209672)
52. Coca SG, Parikh CR. Urinary biomarkers for acute kidney injury: perspectives on translation. Clin J Am Soc Nephrol 2008; 3: 481-490.
53. Devarajan P. Proteomics for biomarker discovery in acute kidney injury. Semin Nephrol 2007; 27: 637-651. (Pubitemid 350180173)
54. Merchant ML, Klein JB. Proteomics and diabetic nephropathy. Semin Nephrol 2007; 27: 627-636. (Pubitemid 350180170)
55. Rossing K, Mischak H, Dakna M et al. Urinary proteomics in diabetes and CKD. J Am Soc Nephrol 2008; 19: 1283-1290.
56. Haubitz M, Wittke S, Weissinger EM et al. Urine protein patterns can serve as diagnostic tools in patients with IgA nephropathy. Kidney Int 2005; 67: 2313-2320. (Pubitemid 41623391)
57. Smith MP, Banks RE, Wood SL et al. Application of proteomic analysis to the study of renal diseases. Nat Rev Nephrol 2009; 5: 701-712.
58. Mischak H, Rossing P. Proteomic biomarkers in diabetic nephropathy-reality or future promise? Nephrol Dial Transplant 2010; 25: 2843-2845.
59. Yamamoto T. Proteomics database in chronic kidney disease. Adv Chronic Kidney Dis 2010; 17: 487-492.
60. Fiedler GM, Baumann S, Leichtle A et al. Standardized peptidome profiling of human urine by magnetic bead separation and matrixassisted laser desorption/ionization time-of-flight mass spectrometry. Clin Chem 2007; 53: 421-428. (Pubitemid 46447938)
61. Fiehn O. Metabolomics-the link between genotypes and phenotypes. Plant Mol Biol 2002; 48: 155-171.
62. Portilla D, Schnackenberg L, Beger RD. Metabolomics as an extension of proteomic analysis: study of acute kidney injury. Semin Nephrol 2007; 27: 609-620. (Pubitemid 350180169)
63. Wishart DS. Metabolomics: a complementary tool in renal transplantation. Contrib Nephrol 2008; 160: 76-87.
64. Mendez-Ferrer S, Michurina TV, Ferraro F et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 2010; 466: 829-834.
65. Lachmann A, Ma'ayan A. Lists2Networks: integrated analysis of gene/protein lists. BMC Bioinformatics 2010; 11: 87.
66. Subramanian A, Tamayo P, Mootha VK et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005; 102: 15545-15550. (Pubitemid 41528093)
67. Gene Ontology Consortium. Creating the gene ontology resource: design and implementation. Genome Res 2001; 11: 1425-1433.
68. Sachs K, Perez O, Pe'er D et al. Causal protein-signaling networks derived from multiparameter single-cell data. Science 2005; 308: 523-529. (Pubitemid 40570578)
69. Guan Y, Myers CL, Lu R et al. A genomewide functional network for the laboratory mouse. PLoS Comput Biol 2008; 4: e1000165.
70. Snel B, Lehmann G, Bork P et al. STRING: a web-server to retrieve and display the repeatedly occurring neighbourhood of a gene. Nucleic Acids Res 2000; 28: 3442-3444.
71. Alexeyenko A, Sonnhammer EL. Global networks of functional coupling in eukaryotes from comprehensive data integration. Genome Res 2009; 19: 1107-1116.
72. Margolin AA, Nemenman I, Basso K et al. ARACNE: an algorithm for the reconstruction of gene regulatory networks in a mammalian cellular context. BMC Bioinformatics 2006; 7(Suppl 1): S7.
73. Tanay A, Sharan R, Kupiec M et al. Revealing modularity and organization in the yeast molecular network by integrated analysis of highly heterogeneous genomewide data. Proc Natl Acad Sci USA 2004; 101: 2981-2986. (Pubitemid 38327722)
74. Friedman RC, Farh KK, Burge CB et al. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009; 19: 92-105.
75. Chatr-aryamontri A, Ceol A, Peluso D et al. VirusMINT: a viral protein interaction database. Nucleic Acids Res 2009; 37: D669-D673.
76. Ma'ayan A, Jenkins SL, Goldfarb J et al. Network analysis of FDA approved drugs and their targets. Mt Sinai J Med 2007; 74: 27-32. (Pubitemid 46957753)
77. Ma'ayan A. Network integration and graph analysis in mammalian molecular systems biology. IET Syst Biol 2008; 2: 206-221.
78. Thomas S, Abdulhay E, Baconnier P et al. SAPHIR-a multi-scale, multiresolution modeling environment targeting blood pressure regulation and fluid homeostasis. Conf Proc IEEE Eng Med Biol Soc 2007; 2007: 6649-6652.
79. Thomas SR, Baconnier P, Fontecave J et al. SAPHIR: a physiome core model of body fluid homeostasis and blood pressure regulation. Philos Transact A Math Phys Eng Sci 2008; 366: 3175-3197.
80. Karaaslan F, Denizhan Y, Kayserilioglu A et al. Long-term mathematical model involving renal sympathetic nerve activity, arterial pressure, and sodium excretion. Ann Biomed Eng 2005; 33: 1607-1630. (Pubitemid 41801646)
81. Guyton AC, Coleman TG, Granger HJ. Circulation: overall regulation. Annu Rev Physiol 1972; 34: 13-46.
82. Ikeda N, Marumo F, Shirataka M et al. A model of overall regulation of body fluids. Ann Biomed Eng 1979; 7: 135-166. (Pubitemid 10105483)
83. Chandhoke PS, Saidel GM, Knepper MA. Role of inner medullary collecting duct NaCl transport in urinary concentration. Am J Physiol 1985; 249: F688-F697. (Pubitemid 16196090)
84. Stephenson JL, Mejia R, Tewarson RP. Model of solute and water movement in the kidney. Proc Natl Acad Sci USA 1976; 73: 252-256.
85. Weinstein AM. Mathematical models of renal fluid and electrolyte transport: acknowledging our uncertainty. Am J Physiol Renal Physiol 2003; 284: F871-F884. (Pubitemid 36443571)
86. Feldberg R, Colding-Jorgensen M, Holstein-Rathlou NH. Analysis of interaction between TGF and the myogenic response in renal blood flow autoregulation. Am J Physiol 1995; 269: F581-F593.
87. Just A. Mechanisms of renal blood flow autoregulation: dynamics and contributions. Am J Physiol Regul Integr Comp Physiol 2007; 292: R1-17. (Pubitemid 46089813)
88. Layton HE, Davies JM, Casotti G et al. Mathematical model of an avian urine concentrating mechanism. Am J Physiol Renal Physiol 2000; 279: F1139-F1160. (Pubitemid 32001637)
89. Oken DE, Thomas SR, Mikulecky DC. A network thermodynamic model of glomerular dynamics: application in the rat. Kidney Int 1981; 19: 359-373. (Pubitemid 11145618)
90. Drumond MC, Kristal B, Myers BD et al. Structural basis for reduced glomerular filtration capacity in nephrotic humans. J Clin Invest 1994; 94: 1187-1195. (Pubitemid 24286462)
91. He L, Sun Y, Takemoto M et al. The glomerular transcriptome and a predicted protein-protein interaction network. J Am Soc Nephrol 2008; 19: 260-268. (Pubitemid 351240648)
92. Weinstein AM. Insights from mathematical modeling of renal tubular function. Exp Nephrol 1998; 6: 462-468. (Pubitemid 28439335)
93. Zhai XY, Thomsen JS, Birn H et al. Three-dimensional reconstruction of the mouse nephron. J Am Soc Nephrol 2006; 17: 77-88.
94. Pannabecker TL, Dantzler WH. Three-dimensional architecture of collecting ducts, loops of Henle, and blood vessels in the renal papilla. Am J Physiol Renal Physiol 2007; 293: F696-F704. (Pubitemid 47403339)
95. Nordsletten DA, Blackett S, Bentley MD et al. Structural morphology of renal vasculature. Am J Physiol Heart Circ Physiol 2006; 291: H296-H309.
96. Inkyo-Hayasaka K, Sakai T, Kobayashi N et al. Three-dimensional analysis of the whole mesangium in the rat. Kidney Int 1996; 50: 672-683. (Pubitemid 26274400)
97. Neal CR, Crook H, Bell E et al. Three-dimensional reconstruction of glomeruli by electron microscopy reveals a distinct restrictive urinary subpodocyte space. J Am Soc Nephrol 2005; 16: 1223-1235. (Pubitemid 41716507)
98. Gagliardini E, Conti S, Benigni A et al. Imaging of the porous ultrastructure of the glomerular epithelial filtration slit. J Am Soc Nephrol 2010; 21: 2081-2089.
99. Walker DC, Southgate J. The virtual cell-a candidate co-ordinator for 0middle-out0 modelling of biological systems. Brief Bioinform 2009; 10: 450-461.
100. Roukos DH. Novel clinico-genome network modeling for revolutionizing genotype-phenotype-based personalized cancer care. Expert Rev Mol Diagn 2010; 10: 33-48.
101. Neusser MA, Lindenmeyer MT, Kretzler M et al. Genomic analysis in nephrology-towards systems biology and systematic medicine? Nephrol Ther 2008; 4: 306-311.
102. Rudnicki M, Perco P, Enrich J et al. Hypoxia response and VEGF-A expression in human proximal tubular epithelial cells in stable and progressive renal disease. Lab Invest 2009; 89: 337-346.
103. Song X, Di Giovanni V, He N et al. Systems biology of autosomal dominant polycystic kidney disease (ADPKD): computational identification of gene expression pathways and integrated regulatory networks. Hum Mol Genet 2009; 18: 2328-2343.
104. Lindenmeyer MT, Kretzler M, Boucherot A et al. Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy. J Am Soc Nephrol 2007; 18: 1765-1776. (Pubitemid 46870313)
105. Vakiani E, Basso K, Klein U et al. Genetic and phenotypic analysis of B-cell post-transplant lymphoproliferative disorders provides insights into disease biology. Hematol Oncol 2008; 26: 199-211.
106. van de Vijver MJ, He YD, van't Veer LJ et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002; 347: 1999-2009. (Pubitemid 35461656)
107. Taguma Y, Kitamoto Y, Futaki G et al. Effect of captopril on heavy proteinuria in azotemic diabetics. N Engl J Med 1985; 313: 1617-1620. (Pubitemid 16155665)
108. Lewis EJ, Hunsicker LG, Bain RP et al. The effect of angiotensinconverting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 1993; 329: 1456-1462. (Pubitemid 23335891)
109. Lewis EJ, Hunsicker LG, Clarke WR et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001; 345: 851-860.
110. Brenner BM, Cooper ME, de Zeeuw D et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001; 345: 861-869.
111. Parving HH, Lehnert H, Brochner-Mortensen J et al. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 2001; 345: 870-878.
112. Freedman BI, Wuerth JP, Cartwright K et al. Design and baseline characteristics for the aminoguanidine Clinical Trial in Overt Type 2 Diabetic Nephropathy (ACTION II). Control Clin Trials 1999; 20: 493-510. (Pubitemid 29460926)
113. Thornalley PJ. Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts. Arch Biochem Biophys 2003; 419: 31-40. (Pubitemid 37279141)
114. Ratnam KK, Feng X, Chuang PY et al. Role of the retinoic acid receptoralpha in HIV-associated nephropathy. Kidney Int 2011; 79: 624-634.
115. Berger SI, Ma'ayan A, Iyengar R. Systems pharmacology of arrhythmias. Sci Signal 2010; 3: ra30.
116. Perco P, Muhlberger I, Mayer G et al. Linking transcriptomic and proteomic data on the level of protein interaction networks. Electrophoresis 2010; 31: 1780-1789.
117. Baelde HJ, Eikmans M, Doran PP et al. Gene expression profiling in glomeruli from human kidneys with diabetic nephropathy. Am J Kidney Dis 2004; 43: 636-650. (Pubitemid 38401879)
118. Moczulski DK, Fojcik H, Wielgorecki A et al. Expression pattern of genes in peripheral blood mononuclear cells in diabetic nephropathy. Diabet Med 2007; 24: 266-271.
119. Sharma K, Lee S, Han S et al. Two-dimensional fluorescence difference gel electrophoresis analysis of the urine proteome in human diabetic nephropathy. Proteomics 2005; 5: 2648-2655. (Pubitemid 40966492)
120. Rao PV, Lu X, Standley M et al. Proteomic identification of urinary biomarkers of diabetic nephropathy. Diabetes Care 2007; 30: 629-637. (Pubitemid 46354345)
121. Mischak H, Kaiser T, Walden M et al. Proteomic analysis for the assessment of diabetic renal damage in humans. Clin Sci (Lond) 2004; 107: 485-495. (Pubitemid 39506740)
122. Kim HJ, Cho EH, Yoo JH et al. Proteome analysis of serum from type 2 diabetics with nephropathy. J Proteome Res 2007; 6: 735-743.
123. Meier M, Kaiser T, Herrmann A et al. Identification of urinary protein pattern in type 1 diabetic adolescents with early diabetic nephropathy by a novel combined proteome analysis. J Diabetes Complications 2005; 19: 223-232. (Pubitemid 40910204)
124. Chi SW, Zang JB, Mele A et al. Argonaute HITS-CLIP decodes microRNAmRNA interaction maps. Nature 2009; 460: 479-486.
125. Berger SI, Posner JM, Ma'ayan A. Genes2Networks: connecting lists of gene symbols using mammalian protein interactions databases. BMC Bioinformatics 2007; 8: 372.
126. Lachmann A, Ma'ayan A. KEA: kinase enrichment analysis. Bioinformatics 2009; 25: 684-686.
127. Wishart DS, Knox C, Guo AC et al. DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res 2008; 36: D901-D906. (Pubitemid 351149842)